Dr. Bose is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 Fourth St.
San Francisco, CA 94158Phone+1 415-476-4616Fax+1 415-353-7107
Summary
- Dr. Rohit Bose is an oncologist at UCSF in San Francisco, CA. He received his medical degree from University of Toronto Faculty of Medicine and has been in practice 10 years. He specializes in genitourinary oncology and is experienced in prostate cancer.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2016
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2008 - 2010
- University of Toronto Faculty of MedicineClass of 2008, MD PhD
Certifications & Licensure
- CA State Medical License 2018 - 2026
- NY State Medical License 2014 - 2018
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Young Investigator Award Prostate Cancer Foundation, 2016
- Merit Award, Genitourinary Cancers Symposium American Society of Clinical Oncology, 2016
- Physician Research Training Award US Department of Defense, Prostate Cancer Program, 2015
- Join now to see all
Publications & Presentations
PubMed
- Patients Can Administer Mobile Audio Recordings to Increase Knowledge in Advanced Prostate Cancer.Daniel H Kwon, Lauren Trihy, Nika Darvish, Eliza Hearst, Saffanat Sumra
Cancer Medicine. 2024-11-01 - 14 citationsSingle-doseLu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 t...Rahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, Vadim Koshkin, Rohit Bose
The Lancet. Oncology. 2023-11-01 - 4 citationsImpact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfo...Tanya Jindal, Li Zhang, Prianka Deshmukh, Kevin Reyes, Emily Chan
Clinical Genitourinary Cancer. 2023-10-01
Journal Articles
- ERF mutations reveal balance of positive and negative ETS factors controlling prostate cancerBose R, Karthaus W, Armenia J, Abida W, Iaquinta P, Wongvipat J, Wasmuth E, Shah N, Doran M, Wang P, Sullivan P, Patruno A, International SU2C/PCF Prostate Cancer Drea..., Nature, 1/1/2017
- Income and spending patterns among panhandlersBose, R. and Hwang, S.W., Canadian Medical Association Journal, 1/1/2002
- Spectroscopic characterization by laser flash photolysis of electrophilic intermediates derived from 4-aminostilbenes Stilbene nitrenium ions and quinone methide iminesBose, R., Ahmad, A., Dicks, A., Kayser, K. and McClelland, R., Perkin Transactions, 1/1/1999
Books/Book Chapters
Abstracts/Posters
- Randomized Phase IB/II Study of Enzalutamide with and without Ribociclib in Patients with Metastatic Castrate Resistant, Chemotherapy Naive Prostate Cancer that Retain...Kelly, W, Godwin J, Hoffman-Censits J, Knudsen K, De Leeuw R, Leiby B, Southwell T, Hubert C, Smith D, Chatta G, Aghalar J, Scher H, Bose R, Autio K, Abida W, Slovin S..., GU ASCO, San Francisco, 1/1/2018
Press Mentions
- $35M Gift from Benioffs to Support Prostate Cancer Research Initiative at UCSFOctober 10th, 2019
- UCSF Launches New Initiative to Accelerate Prostate Cancer ResearchSeptember 23rd, 2019
- Researchers Unravel the Biology of a Distinct Prostate Cancer SubtypeJune 26th, 2019
- Join now to see all
Professional Memberships
- Member
- Member
External Links
- Bose Lab Websitehttp://boselab.ca
- Clinical Websitehttps://www.ucsfhealth.org/en/providers/dr-rohit-bose
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: